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Abstract 
Background: Urtica dioica has traditionally been used in the management of cardiovascular disorders especially 
hypertension. The aim of this study was to explore pharmacological base of its use in hypertension.
Methods: Crude methanolic extract of U. dioica (Ud.Cr) and its fractions (Ud.EtAc, Ud.nHex, Ud.Chl and Ud.Aq) were 
tested in vivo on normotensive and hypertensive rats under anesthesia for blood pressure lowering effect. In‑vitro 
experiments on rat and rabbit aortae were employed to probe the vasorelaxation mechanism(s). The responses were 
measured using pressure and force transducers connected to PowerLab Data Acquisition System.
Results: Ud.Cr and fractions were found more effective antihypertensive in hypertensive rats than normotensive 
with remarkable potency exhibited by the ethyl acetate fraction. The effect was same in the presence of atropine. In 
isolated rat aortic rings, Ud.Cr and all its fractions exhibited l‑NAME sensitive endothelium‑dependent vasodilator 
effect and also inhibit K+ (80 mM)‑induced pre‑contractions. In isolated rabbit thoracic aortic rings Ud.Cr and its frac‑
tions induced relaxation with more potency against K+ (80 mM) than phenylephrine (1 µM) like verapamil, showing 
Ud.EtAc fraction the most potent one. Pre‑incubation of aortic rings with Ud.Cr and its fractions exhibited Ca2+ chan‑
nel blocking activity comparable with verapamil by shifting Ca2+ concentration response curves to the right. Ud.Cr 
and its fractions also ablated the intracellular Ca2+ release by suppressing PE peak formation in Ca2+ free medium. 
When tested on basal tension, the crude extract and all fractions were devoid of any vasoconstrictor effect.
Conclusions: These data indicate that crude methanolic extract and its fractions possess antihypertensive effect. 
Identification of NO‑mediated vasorelaxation and calcium channel blocking effects explain the antihypertensive 
potential of U. dioica and provide a potential pharmacological base to its medicinal use in the management of 
hypertension.
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Background
Urtica dioica L., (Urticaceae) is one of such plants, used 
by local practitioners for various human ailments [1]. 
Urtica dioica is commonly known as “Nettle”, which 
comes from word meaning “textile plant” because of its 
use in the production of silky fabrics [2, 3]. Locally it is 
known as “Bichu bute” in Urdu, “Kali and Kandale” in 
Hindko and “Zhoomi joomi” in Shina. It is found in dif-
ferent areas of Pakistan like Hazara Division, Gilgit Bal-
tistan, Naran, Kaghan and Balochistan. In addition to 
this, it is widely distributed throughout the USA, Europe 
and Himalaya naturally, as well as cultivated commer-
cially [4].
Urtica dioica is an annual growing to 0.6 m tall shrub 
which bears opposite, cordate, deeply serrate, pointed 
leaves which are downy underneath. Flowering and fruit-
ing time is from June to October. The stem and leaves 
of the plant are covered with stinging trichomes. The 
fluid present in the trichomes is histamine, 5-hydroxyl 
tryptamine, acetylcholine, small amount of formic acid 
and leukotrienes which enter the skin and causes blister-
ing. The plant prefers to grow on loose soil with organic 
matter rich in nitrogen and high phosphate levels for 
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seeds or vegetative by divisions. It is a relief that nettles 
can be established from cuttings so there is potential to 
cultivate both male and female forms [5].
Traditionally U. dioica has been used for the treatment 
of hypertension, gastro intestinal, hepatic disorders [6] 
and diabetes [7, 8].
The extract of this plant contains different chemical 
compounds including neophytadiene (25.21 %), sinapic 
acid (25  %), phthalic acid (8.15  %), dibutyl phthalate 
(7.37  %), bis(2‐ethyl hexyl) maleate (6.32  %) and 1,2‐
benzene di carboxylic acid (7.62 %) [9]. Nettle is nutri-
tionally high in vitamins A, C and D, also minerals iron, 
manganese, potassium and calcium [5]. Neophytadi-
ene and sinapic acid are reported to be an antibacterial 
compound [10]. Neophytadiene is suitable for treat-
ment of headache, rheumatism and some skin diseases 
[11]. Aromatic compounds including carboxylic acids 
and esters were also reported in this plant [12]. Finally, 
fat acids including phthalic acid, dibutyl ester, bis(2‐ 
ethyl hexyl) maleate and 1,2‐benzenedi carboxylic acid 
were isolated. These compounds are reported to have 
anti-putrefying [13] and antimicrobial effects [14]. 
Urtica dioica exerts different pharmacological effects, 
such as a stimulation of human lymphocyte prolifera-
tion [15], an anti-inflammatory [16], and used in the 
treatment of prostatic hyperplasia [17]. There are also 
reports of diuretic and natriuretic effects of U. dioica 
[18].
The reported diuretic activity and traditional medici-
nal use of U. dioica in hypertension indicates it might 
have beneficial effects on the cardiovascular system. 
This investigation was therefore carried out to explore 
the antihypertensive potential and underlying vascular 




Dried rhizome of U. dioica L., were purchased from a 
known herbalist (Ali Pansar, Sargodha) in Sargodha, 
Punjab, Pakistan and identified by botanist Dr. Ghulam 
Murtuza Shah, Assistant Professor, Post Graduate Col-
lege, Abbottabad. The sample voucher (Ud.Rh.08/12) was 
deposited to the Department of Pharmacy, COMSATS 
Institute of Information Technology, Abbottabad. After 
cleaning of adulterant material, the rhizomes were 
ground into coarse powder. Extraction and fractionation 
was carried out as described previously [19]. About 5 kg 
of coarse powder was soaked in methanol at room tem-
perature (23–25 °C) for 15 days with occasional shaking. 
It was filtered through eightfold muslin cloth and then 
through a Whatman qualitative grade 1 filter paper. This 
procedure was repeated twice and the combined filtrate 
was evaporated on rotary evaporator under reduced 
pressure, yielding approximately 10.81  % crude extract 
(Ud.Cr).
Fractionation was carried out, using solvents of 
increasing polarity. Ud.Cr was mixed in distilled water 
and equal volume of nHexane was added to it and shaken 
vigorously in a separating funnel. The nHexane, upper 
layer was collected and evaporated on rotary evaporator 
to give the nHexane fraction (Ud.nHex: yielding 16  %). 
The lower layer was taken in a separating funnel, and 
equal volume of chloroform was added. The chloroform 
layer (lower) was collected and evaporated on rotary 
evaporator to obtain the chloroform fraction (Ud.Chl: 
yielding 24  %). The other layer (upper) was again taken 
into a separating funnel, ethyl acetate was added into it, 
separated and was also evaporated in rotary evaporator 
to give the ethyl acetate fraction (Ud.EtAc: yielding 21 %). 
The remaining lower layer was collected, evaporated 
and considered as the aqueous fraction (Ud.Aq: yielding 
39 %).
Chemicals
Acetylcholine chloride (ACh), atropine sulphate, phe-
nylephrine hydrochloride (PE), norepinephrine (NE), 
potassium chloride, Nω-nitro l-arginine methyl ester 
(l-NAME) hydrochloride and verapamil hydrochloride 
were purchased from Sigma Chemicals Company, St. 
Louis, MO, USA. Pentothal sodium and heparin injec-
tions were obtained from Abbot Laboratories, Karachi, 
Pakistan and F. Hoffmann-La Roche, Basel, Switzerland, 
respectively. Stock solutions of the drugs were made in 
distilled water/saline and the subsequent dilutions were 
prepared fresh on the day of experiment.
Experimental animals and housing conditions
Rabbits (1–1.5 kg) and Sprague–Dawley rats (200–220 g) 
preferably male and local bred were housed at the Ani-
mal House of the COMSATS Institute of Informa-
tion Technology, Abbottabad, maintained at 23–25  °C. 
Experiments performed complied with the rulings of 
the Institute of Laboratory Animal Resources, Commis-
sion on Life Sciences, National Research Council [20] 
and approved by the Ethical Committee of COMSATS 
Institute of Information Technology, Abbottabad, in 
its meeting held on 17-06-2013 vide notification EC/
PHM/07-2013/CIIT/ATD.
In‑vivo experiments
Blood pressure measurement in normotensive anesthetized 
rats
These experiments were performed on male Sprague- 
Dawley rats (200–220  g) as described [21]. Animals 
were anesthetized with an intra-peritoneal injection of 
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sodium thiopental (pentothal, 40–100 mg/kg), fixed in a 
supine position on a dissecting table; a small mid tracheal 
incision (approximately 1  cm) was made to expose tra-
chea, right jugular vein, and carotid artery. The trachea 
was cannulated with a polyethylene tubing PE-20 and 
cleaned from time to time to maintain the spontaneous 
respiration. The right jugular vein was cannulated with 
a polyethylene tubing PE-50 to facilitate the intravenous 
infusions of the standard drugs and test materials. The 
carotid artery was cannulated with similar tubing filled 
with heparinized saline (60  IU/mL) and connected to a 
pressure transducer coupled with PowerLab (ML 846) 
Data Acquisition System (ADInstruments Australia). 
This connection was used for blood pressure recording. 
The exposed surface was covered with a piece of tissue 
paper moistened with warm saline. Rats were infused 
with heparinized saline (0.1  mL) to prevent blood clot-
ting. The body temperature of the animal was maintained 
by using an overhead lamp.
Experimental protocol
After 20–30  min of the equilibrium period, acetylcho-
line and norepinephrine were used to check the stabil-
ity of the animals toward hypotensive and hypertensive 
responses, respectively. Acetylcholine (1 µg/kg) in a vol-
ume of 0.1 mL was slowly injected followed by a flush of 
0.1 mL saline, which caused a fall in blood pressure. After 
approximately 5–10 min later, when the normal pattern 
of blood pressure was resumed, norepinephrine (1 µg/kg) 
was slowly injected followed by a flush of 0.1 mL saline, 
which caused an increase in blood pressure. After resum-
ing the normal pattern of blood pressure, rats were then 
injected intravenously with 0.1  mL saline or with the 
same volume of test substances. The mean arterial pres-
sure (MAP) was allowed to return to the resting level 
between injections. Drugs, extract, and their fractions 
were then injected intravenously and followed by a flush 
with 0.1 mL saline. Changes in MAP were recognized as 
the difference between the steady-state values before and 
the lowest readings after injection. The MAP was calcu-
lated as the diastolic blood pressure (BP) plus one-third 
pulse width (systolic BP–diastolic BP).
Blood pressure measurement in hypertensive anesthetized 
rats
The protocol of Lawler et  al. and Vasdev et  al. [22, 23] 
was followed with some modifications. Sprague–Dawley 
male rats (200–220 g; n = 5) were hygienically housed in 
uniform conditions. The rats were given high-salt (8  % 
NaCl) diet and water ad  libitum for 6-weeks. One day 
prior to the experiment, the rats were given normal diet 
and water. Subsequently the rats were used for in  vivo 
blood pressure measurement as described earlier.
In‑vitro experiments
Rat thoracic aorta
The procedure of Taqvi et  al. [24] was followed with 
some modifications. Thoracic aorta was isolated from 
Sprague–Dawley rats of normotensive and high salt-
induced hypertensive rats carefully to avoid any damage 
to the endothelium. The aorta was then transferred into 
the Kreb’s solution aerated with carbogen (5 % CO2 in O2). 
The composition of Kreb’s solution was (mM): NaCl 118.2, 
NaHCO3 25.0, CaCl2 2.5, KCl 4.7, KH2PO4 1.3, MgSO4 
1.2 and glucose 11.7 (pH 7.4). It was cautiously cleaned off 
fats and other connective tissues and then cut into rings 
2–3 mm wide. In some rings, the endothelium was inten-
tionally removed by gentle rubbing of the intimal surface 
with forceps. The rings with intact endothelium that pro-
duced less than 80 % relaxation in response to acetylcholine 
(1 µM) were tossed away. Individual rings were suspended 
in 10 mL tissues baths at 37  °C aerated with carbogen. A 
preload of 1  g was applied to each preparation and incu-
bated for 30  min. Changes in isometric tension were 
recorded and analyzed through a force transducer (MLT 
0201) coupled with a bridge amplifier (N12128) and Pow-
erLab (ML 846) Data Acquisition System (ADInstruments).
Endothelium‑dependent and‑independent effects
A series of experiments were conducted to assess 
endothelium-dependent or independent effects of Ud.Cr 
and its fractions on isolated aortic rings of normotensive 
and hypertensive rats. When the tension was at resting 
state or reached a plateau induced by PE (1 µM), Ud.Cr 
and its fractions (mg/mL) were cumulatively added 
into the organ bath. The rings with intact and denuded 
endothelium were always tested in parallel. To determine 
the underlying mechanisms, endothelium-intact rings 
were incubated with l-NAME (10 µM), for 30 min before 
the addition of PE. The test material was then added 
cumulatively and the concentration response curves 
(CRCs) were constructed for the inhibitory responses.
K+ (80 mM) was also used to depolarize the tissue, which 
produced sustained contractions and allowed to study 
the effect on the VDCs. The test material was then added 
cumulatively and relaxation was expressed as the percent of 
the contractions induced by K+ (80 mM). This protocol was 
used to see if there is difference in vascular reactivity in two 
different vascular preparations from different species [25].
Rabbit thoracic aorta
As described previously [22, 25] rabbits were killed by 
a blow on the back of the head; the thoracic aorta was 
removed and cut into rings of approximately 2–3  mm 
width. Aortic rings were suspended between a pair of 
stainless steel hooks in 10 mL organ baths, one hook was 
anchored to a steel rod at the bottom and the other was 
Page 4 of 13Qayyum et al. J Transl Med  (2016) 14:254 
attached to a force transducer (MLT 0201). The tissues 
were suspended in normal Kreb’s solution, maintained at 
37 °C, and continuously bubbled with 5 % CO2 in O2 (car-
bogen). A resting tension of 2 g was applied to each tis-
sue and an equilibrium period of 1 h was allowed before 
studying the effect of test materials. Phenylephrine 
(1  µM) was used to stabilize the preparations. Changes 
in isometric tension were recorded and analyzed through 
a force transducer coupled with a bridge amplifier and 
PowerLab Data Acquisition System (ADInstruments, 
Sydney, Australia).
Effect on contraction induced by phenylephrine and K+ 
(80 mM)
The protocol of Chan et al. [26] was followed with some 
modifications. Phenylephrine (1 µM) or high K+ (80 mM) 
was used to induce steady-state contractions. The plant 
extract and its fractions were added cumulatively to 
obtain concentration response relationship and the relax-
ation was expressed as percent of agonist-induced con-
tractions. Vascular reactivity of the extract was evaluated 
on Ca2+ influx either through voltage-dependent (VDCs) 
or receptor-operated Ca2+ channels (ROCs) and Ca2+ 
release from internal store(s).
Determination of calcium channel blocking activity
In the first set of experiments, an attempt was made to 
see if the relaxation induced by the extract involved Ca2+ 
influx through VDCs. Aortic rings were washed four to 
five times with Ca2+-free solution before the construc-
tion of control CRCs of Ca2+ (as CaCl2). When the con-
trol CRCs of Ca2+ were found superimposable (usually 
after two cycles), then tissue was pretreated with the 
plant extract for 30–45 min to test the possible calcium 
channel blocking effect. A parallel control was also run 
under similar experimental conditions. A second set of 
experiments was used to elucidate whether Ud.Cr and 
its fractions induce relaxation through ROCs. Aortic 
rings were washed four to five times with normal Kreb’s 
solution and the effect of Ud.Cr and its fractions was 
determined on PE (1  µM)-induced sustained contrac-
tions [22].
Effect on intracellular Ca 2+ stores
In a set of experiments, the aim was to clarify whether the 
relaxation induced by Ud.Cr and its fractions is related to 
inhibition of intracellular Ca2+. The rings were exposed 
to Ca2+-free solution for 15  min before the application 
of PE (1  µM) to induce the first transient contraction. 
The composition of Ca2+-free/EGTA Kreb’s solution was 
(mM): NaCl 118.2, NaHCO3 25.0, KCl 4.7, KH2PO4 1.3, 
MgSO4 1.2, EGTA 0.05, and glucose 11.7 (pH 7.4). The 
rings were then washed three times with normal Kreb’s 
solution and incubated for at least 40 min for refilling of 
the intracellular stores. Subsequently, the medium was 
rapidly replaced with Ca2+-free solution and the rings 
were incubated for another 15 min. The second contrac-
tion was then induced by PE (1  µM) in the presence of 
Ud.Cr and its fractions (mg/mL), which were added 
30  min before the application of PE, both contractions 
were compared [22].
Statistical analysis
Data obtained from the animal and in  vitro experi-
ments were expressed as the mean  ±  standard error 
(±SEM). Statistical difference between the treatments 
and the control were evaluated by a one-way analysis of 
variance(ANOVA) followed by Tukey’s multiple compar-
ison test using IBM SPSS software (Version 20, SPSS Inc., 
Chicago, IL). Differences were considered significant at 
*p < 0.05, **p < 0.01, and ***p < 0.001.
Results
Effect on blood pressure in normotensive anesthetized rats
Before the administration of the crude extract and frac-
tions of U. dioica L., standard drugs such as acetylcholine 
and norepinephrine were used, they caused a fall and rise 
in MAP, respectively (Fig. 1a). The MAP in normotensive 
and high salt induced hypertensive rats was 115 ±  5.12 
(n =  20) and 166 ±  4.45 (n =  20), respectively. In nor-
motensive rats under anesthesia, intravenous administra-
tion of Ud.Cr caused a fall in MAP (Fig. 1a). The % fall in 
MAP at respective doses of 1, 3, 10, 30 and 50 mg/kg was 
1.68 ± 2.3, 10.74 ± 1.8, 13.85, 7 ± 2.7, 28.81 ± 3.7 and 
61.00 ±  8.06 (Fig.  1d). Among fractions tested, all frac-
tions caused a fall in MAP, but the ethyl acetate fraction 
being the most potent at 50 mg/kg (76.00 ± 3.77) (Fig. 2). 
The percent fall in each case was statistically different 
(p < 0.05) compared to pre-treated values among the dif-
ferent doses. To check the possibility of involvement of 
muscarinic receptors, rats were pre-treated with atropine 
(1  mg/kg). This pretreatment did not affect the blood 
pressure lowering effect of the extract and fractions (data 
not shown). 
Effect on blood pressure in hypertensive anesthetized rats
In hypertensive rats under anesthesia, intravenous 
administration of Ud.Cr caused a fall in MAP more than 
the normotensive rats. The % fall in MAP at respec-
tive doses of 1, 3, 10, 30 and 50  mg/kg was 5.00 ±  3.4, 
14.66 ± 1.5, 21.00 ± 0.27, 42.33 ± 0.95 and 69.33 ± 2.51 
(Fig.  2). All fractions have blood pressure lower-
ing effect, but the ethyl acetate fraction was the most 
potent (p < 0.05), which caused a fall in MAP 9.33 ± 1.9, 
38.33 ± 1.25, 55.00 ± 1.7, 76.00 ± 4.1 and 96.00 ± 3.77 
(Fig. 2). Pretreatment of the rats with atropine (1 mg/kg) 
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did not affect blood pressure lowering effect of the frac-
tions (data not shown) (Fig. 2).
Endothelium‑dependent and‑independent effects
In rat aortic rings acetylcholine failed to induce less than 
80 % relaxation were excluded. In aortic rings with intact 
endothelium pre-contracted with PE (1 µM), cumulative 
addition of Ud.Cr caused endothelium-dependent relaxa-
tion with EC50 value of 0.28  mg/mL (0.11–0.37). Pre-
treatment of intact aortic rings with l-NAME (10  µM) 
inhibited the vasorelaxant effect of Ud.Cr with EC50 value 
of 2.91  mg/mL (1.25–3.0) and shifted the CRCs to the 
right (Fig. 3a).
In denuded endothelium pre-contracted with PE 
(1 µM), Ud.Cr relaxed the tissue at higher concentrations 
with EC50 value of 2.91 mg/mL (1.02–3.0) and shifted the 
CRCs to the right as compared to intact endothelium. 
In aorta rings of hypertensive rats pre-contracted with 
PE, Ud.Cr relaxed the tissue at higher concentrations 
with overlapping EC50 value of 2.91  mg/mL (1.02–3.01) 
observed in the presence of l-NAME or denuded aorta 
(Fig. 3a).
Intact rat aorta rings pre-contracted with PE (1  µM), 
cumulative addition of Ud.nHexane induced endothe-
lium-dependent vasorelaxation. This relaxation was 
inhibited in intact aortic rings pre-treated with l-NAME 
(10 µM), aortic rings without endothelium and in rings of 
hypertensive rats. Chloroform and aqueous fractions also 
induced endothelium-dependent vasorelaxation, simi-
lar to the parent crude extract. Interestingly, the effect 
of ethyl acetate fraction was about 60 times more potent 
in the aortic rings with intact endothelium, compared 
to intact rings pretreated with l-NAME and in denuded 
aortic rings (Fig. 3).
To see effect on vascular smooth muscles, high K+ 
(80  mM) was used. Cumulative addition of the extract 
and fractions induced relaxation with varying potencies 
(Fig.  4a). The ethyl acetate fraction being more potent 
while the aqueous fraction was least, which induced 
partial inhibition (Fig.  4). Verapamil, a typical calcium 
channel blocker induced endothelium-independent vaso-
dilator effect (data not shown) with more potency against 
high K+ precontractions (Fig. 4b), as expected.
Effect on calcium channels
Rabbit aortic rings were used to see effect of the 
extract and fractions on Ca2+ movements through 
VDCs and store-operated Ca2+ channels. Rabbit aor-
tic rings pre-contracted with PE and high K+, extract 
was added cumulatively, which induced a vasodilator 
effect with more potency against high K+ than PE with 
EC50 values of 0.49  mg/mL (0.31–1.75) and 2.19  mg/
mL (1.07–3.77), respectively, similar to verapamil 
(Fig.  5a, c). Pre-incubation of the aortic rings with 
Ud.Cr (0.1–1.0  mg/mL) shifted the Ca2+ CRCs to the 
right (Fig. 5b), constructed in Ca2+-free medium, simi-
lar to that caused by verapamil (Fig. 5d).
Ethyl acetate fraction was more potent than the par-
ent extract, it induced relaxation of high K+and PE pre-
contractions with EC50 values of 5.14 (3.98–6.31) and 
2.02 mg/mL (1.58–2.51), respectively (Fig. 6a). The nHex-
ane fraction was similar to the parent crude extract in 
potency. However, the chloroform fraction was more and 
the aqueous fraction was least potent (Fig. 6).
Effect on calcium stores
In a series of experiments designed to show the effect 
of Ud.Cr and its fractions on the transient contractile 
Fig. 1 A representative tracing a showing the effect of norepineph‑
rine (NE), acetylcholine (Ach), and different doses of crude extract 
of U. dioica (Ud.Cr) on mean arterial pressure (MAP) in normotensive 
rats under anesthesia. b The hypertensive and hypotensive effects 
of norepinephrine (NE) and acetylcholine (ACh), respectively. c The 
blood pressure of normotensive and hypertensive rats. d The effect 
of crude extract of U. dioica (Ud.Cr) on MAP in normotensive and 
hypertensive rats, under anesthesia (n = 6–7), *p < 0.05, **p < 0.01, 
and ***p < 0.001 represent the significance difference between the % 
fall in MAP on normotensive and hypertensive rats
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response induced by PE (1 µM), pretreatment of the tis-
sues with Ud.Cr (0.01–10.0  mg/mL) suppressed the PE 
peak formation in Ca2+ –free medium (Fig.  7), similar 
to that caused by verapamil. The ethyl acetate, nHexane, 
chloroform, and aqueous fractions (0.01–10.0  mg/mL) 
also suppressed the transient contractile response of PE 
(Fig. 7).
Discussion
For thousands of years, medicine and natural products 
have been closely interconnected through the use of tra-
ditional medicine. Despite competition from other drug 
discovery methods, natural products are still providing 
their fair share of new clinical candidates [25]. Urtica 
dioica is traditionally used for the treatment of hyperten-
sion [4].
The aim of this study was to confirm the medicinal 
importance of U. dioica in hypertension. Invasive blood 
pressure monitoring technique was used. This protocol 
allowed us to observe the effect of extract and fractions 
directly injected into the systemic circulation. Intrave-
nous injection of the methanolic extract of U. dioica 
and its fractions caused a dose-dependent fall in MAP 
in both normotensive and hypertensive rats. However 
Fig. 2 Graphs show the effect of a ethylacetate (Ud.EtAc) b nHexane (Ud.nHex), c chloroform (Ud.Chl) and d aqueous (Ud.Aq) fractions of U. dioica 
on mean arterial pressure (MAP) in normotensive and hypertensive rats, under anesthesia. Values shown are mean ± SEM (n = 6–7) *p < 0.05, 
**p < 0.01, and ***p < 0.001 represent the significance difference between the % fall in MAP on normotensive and hypertensive rats
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Fig. 3 a–f The response of crude extract of U. dioica (Ud.Cr), its fractions ethyl acetate (Ud.EtAc), nHexane (Ud.nHex), chloroform (Ud.Chl) and aque‑
ous (Ud.Aq) and acetylcholine on PE‑induced contractions in intact (with and without l‑NAME (10 µM) pretreatment), denuded aortic rings from 
normotensive rats and rings from hypertensive rats. Values shown are mean ± SEM (n = 6–7), *p < 0.05, **p < 0.01, and ***p < 0.001
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the effect was more significant in the hypertensive rats. 
When compared to the parent crude extract, ethylacetate 
fraction was more potent, and aqueous fraction was least 
potent. To see if the blood pressure lowering effect of the 
extract and fraction might be mediated through mus-
carinic receptors stimulation, rats were pretreated with 
atropine, a muscarinic receptor antagonist [27]. This pre-
treatment did not affect antihypertensive effect either of 
the extract or fractions. This finding excluded the possi-
bility of muscarinic receptors involvement in the antihy-
pertensive effect of extract or fractions. Blood pressure is 
the product of peripheral resistance and cardiac output 
[28]. Therefore, further in vitro experiments were carried 
out in isolated vascular preparations to determine the 
underlying mechanisms of antihypertensive effect.
In isolated rat thoracic aorta, Ud.Cr and its fractions 
induced vasorelaxation on phenylephrin pre-contrac-
tions. To see the involvement of mediators of endothe-
lium origin, such as NO and prostaglandins, the aortic 
rings were pretreated with l-NAME, NO synthase inhib-
itor [29] and indomethacin, a prostaglandin inhibitor 
[30]. Aortic ring pretreated with l-NAME ablated the 
vasorelaxation induced by the crude extract; however 
indomethacin pretreatment did not affect this relaxation. 
This indicates that NO is involved in the vasorelaxation 
induced by the crude extract and prostaglandin, such as 
PGI2 do not play a role. In aortic rings from hypertensive 
rats, acetylcholine was failed to induce relaxation, indi-
cating endothelium was damaged with high salt treat-
ment. Interestingly, the relaxation induced by the extract 
was ablated in denuded rings from normotensive rats and 
in rings from hypertensive rats, indicates that NO is the 
major endothelial-derived factor involved in the vasore-
laxation. We tested parallel to see if there is any exciting 
activity in the fractions. We found that the nhexane frac-
tion was similar to the parent crude extract. However, 
the chloroform fraction exhibited a mild endothelium-
dependent vasodilator effect while the aqueous frac-
tion induced an endothelium-independent effect. The 
ethylacetate fraction was exciting, it induced a strong 
endothelium-dependent NO mediated vasodilator effect 
with about 60 times more potency than in the intact rings 
pretreated with l-NAME or denuded rings. This find-
ing indicates that ethylacetate fraction is the most active 
among the fractions and explains its antihypertensive 
potency.
Failure of the relaxation induced by the crude extract 
and fractions in the presence of l-NAME, or in denuded 
rings or in rings from hypertensive rats, indicates pres-
ence of constituents act through different vascular 
mechanism(s). We tested this hypothesis in rat aortic 
rings pre-contracted with high K+. High K+ (80  mM) 
is known to cause vascular smooth muscle contractions 
through the opening of voltage dependent L-type Ca2+ 
channels [31], and substance inhibits high K+-induced 
contraction is considered as inhibitor of Ca2+ influx 
[32]. When tested in high K+ (80 mM) precontractions, 
the crude extract and its fractions caused an inhibitory 
effect, may reflect the restricted Ca2+ entry via VDCs 
and can possibly explain the endothelium-independent 
Fig. 4 Graph shows a vasodilator effect of crude extract of U. dioica (Ud.Cr), its fractions ethyl acetate (Ud.EtAc), nHexane (Ud.nHex), chloroform (Ud.
Chl) and aqueous (Ud.Aq) Ud.nHex, b verapamil on high K+ (80 mM)‑induced contractions in isolated rat aorta rings. Values shown are mean ± SEM 
(n = 6–7), *p < 0.05, **p < 0.01, and ***p < 0.001 represent the significance difference between the relaxation of intact and denuded aorta
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component of the vasodilator effect of the extract 
and fractions. We observed that the effect of high K+ 
(80  mM) precontraction was either weak or not repro-
ducible and sustainable. There is sufficient evidence of 
heterogenicity of calcium channels [33], they are differ-
ent in myocardium of rat and rabbit [34] and brain of rat, 
frog and chicken [35]. Therefore, for further studies we 
used rabbit aorta in which the effect of high K+ is strong 
and reproducible. Crude and fractions (except the aque-
ous fraction) induced relaxation of the high K+ and phe-
nylephrine precontractions with more potency against 
high K+ than PE, similar to verapamil. Aqueous fraction 
partially relaxed PE precontractions. The ethylacetate 
fraction was remarkably more potent (about 49 times) 
against high K+ than PE. This suggests role of the crude 
extract and fraction inhibiting Ca2+ moment though 
Fig. 5 The graphs shows the concentration‑dependent vasodilator effect of a crude extract of U. dioica (Ud.Cr), c the Verapamil on phenylephrine 
(PE) and high K+(80 mM) precontractions, b–d respectively, their effect on the Ca2+ concentration–response curves, constructed in Ca2+‑ free 
medium, in isolated rabbit aorta preparations. Values shown are mean ± SEM (n = 6–7), *p < 0.05, **p < 0.01, and ***p < 0.001, represent the signifi‑
cance difference between the relaxation induced by phenylephrine (PE) and high K+ (80 mM)
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VDCs. This hypothesis was further confirmed when aor-
tic rings pretreated with extract and fraction caused a 
rightward shift in the CaCl2 concentration curves, simi-
lar to verapamil.
The relaxation of PE (1  µM) pre-contractions by Ud.Cr 
and its fractions also reflects its inhibitory effects on Ca2+ 
movement through receptor operated calcium chan-
nels (ROCs) and or its release from internal stores. To see 
Fig. 7 Typical tracing showing inhibitory effect of a increasing concentrations of the crude extract of U. dioica (Ud.Cr) on the initial peak formation 
of phenylephrine in Ca2+‑free medium. b The combined effect of Ud.Cr, its ethyl acetate (Ud.EtAc), nHexane (Ud.nHex), chloroform (Ud.Chl), and 
aqueous (Ud.Aq) fractions, and c the effect of verapamil on initial peak formation of PE in isolated rabbit aorta preparations, in Ca2+‑free medium. 
Values shown are mean ± SEM (6–7)
(See figure on previous page.) 
Fig. 6 The graphs shows the concentration‑dependent vasodilator effect of a–g crude extract of U. dioica (Ud.Cr), the Verapamil, ethyl acetate (Ud.
EtAc), nHexane (Ud.nHex), chloroform (Ud.Chl), and aqueous (Ud.Aq) fractions on phenylephrine (PE) and high K+ (80 mM) precontractions, and 
(b–h) respectively, their effect on the Ca2+ concentration–response curves, constructed in Ca2+‑ free medium, in isolated rabbit aorta prepara‑
tions. Values shown are mean ± SEM (n = 6–7), *p < 0.05, **p < 0.01, and ***p < 0.001, represent the significance difference between the relaxation 
induced by phenylephrine (PE) and high K+ (80 mM)
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possible effect on Ca2+ release from the internal store, aor-
tic rings were pretreated with extract and fractions in Ca2+ 
free medium. Interestingly, this pretreatment suppressed 
PE individual contractions, indicating inhibitory effect on 
Ca2+ release from the internal Ca2+ store. Further work 
is required to explore the underlying mechanism of Ca2+ 
release. These data indicate that the extract of U. dioica 
contains antihypertensive and vasodilator constituents act 
on both vascular endothelial and smooth muscle cells and 
release NO and block Ca2+ moments. These two mecha-
nisms support the vasodilator effect of the extract and frac-
tions and explain the underlying antihypertensive activity.
We could not identify any particular constituent(s) in the 
extract responsible for the antihypertensive effect. How-
ever, our preliminary phytochemical analysis indicated 
presence of alkaloids, tannins, flavonoids, saponins, reduc-
ing sugars, cardiac glycosides, steroids and terpenoids in 
the methanolic crude extract of U. dioica. Previous studies 
show that plant derived alkaloids have vasorelaxant prop-
erties through multiple pathways like inhibition of calcium 
release from Ca2+ stores [28] and NO pathways [36]. Glu-
cosides [37] and sesquiterpenes [38] also have an inhibi-
tory effect on the cardiovascular system. We assume that 
these constituents might be the active constituents respon-
sible for the antihypertensive effect of U. dioica.
Conclusion
The current findings on the cardiovascular activities of 
U. dioica and its fractions indicated presence of anti-
hypertensive activity. This antihypertensive effect is 
the outcome of vasodilation induced by the extract and 
fractions. NO release and dual inhibitory effect on Ca2+ 
moments through VDCs and release from internal store 
explains the underlying mechanisms of vasodilation. This 
finding justifies the medicinal application of U. dioica in 
the management of hypertension, however further stud-
ies are required to isolate particular antihypertensive 
constituent and to underlying molecular mechanisms.
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